In an NEJM editorial, Dr. Collins recounts the journey from discovery to targeted therapy for cystic fibrosis
In 1989, Dr. Collins was part of the research team that identified the gene that causes cystic fibrosis. He recounts the 30 year journey from that discovery to the development of a targeted, triple-combination therapy that holds promise for 90% of cystic fibrosis patients. N Engl J Med. Online: October 31, 2019.